Elsevier

Life Sciences

Volume 53, Issue 7, 1993, Pages PL129-PL134
Life Sciences

Pharmacology letter
δ-opioid supraspinal antinociception in mice is mediated by G13 transducer proteins

https://doi.org/10.1016/0024-3205(93)90720-NGet rights and content

Abstract

The intracerebroventricular (i.c.v.) injection to mice of antisera directed against different sequences Gi3α, impaired the antinociception produced by the selective ligands of δ opioid receptors DPDPE and [D-Ala2]-Deltorphin II, when studied 24 h later in the tail-flick test. Likewise, the potency of the μ/δ ligands DADLE, etorphine and β-endorphin-(1–31) was also reduced. Antinociception due to the μ-agonists morphine and DAMGO was slightly altered by this treatment. The selective δ antagonist ICI 174864 significantly reduced the antinociceptive activity of these opioids to the same extent observed after giving anti-Gi3α antisera. In animals treated with the antisera, ICI 174864 failed to reduce the antinociceptive effect that remained. It is concluded that Gi3 is the type of transducer protein regulated by δ opioid receptors to produce supraspinal antinociception in mice.

References (20)

  • P. Sanchez-Blazquez et al.

    European J. Pharmacol.

    (1988)
  • P. Sanchez-Blazquez et al.

    Life Sci.

    (1991)
  • P. Sanchez-Blazquez et al.

    European J. Pharmacol.

    (1989)
  • D.T. Jones et al.

    J. Biol. Chem.

    (1987)
  • J. Garzon et al.

    Life Sci.

    (1983)
  • P. Sanchez-Blazquez et al.

    European J. Pharmacol.

    (1989)
  • R. Cotton et al.

    European J. Pharmacol.

    (1984)
  • M. Parenti et al.

    European J. Pharmacol.

    (1986)
  • K. Hoehn et al.

    European J. Pharmacol.

    (1988)
  • P. Sanchez-Blazquez et al.
There are more references available in the full text version of this article.

Cited by (0)

View full text